(Q38324277)

2 September 2017

1 reference

title

Image-guided ablation of primary liver and renal tumours (English)

1 reference

2 September 2017

David J Breen

1

1 reference

2 September 2017

Riccardo Lencioni

series ordinal

2

1 reference

2 September 2017

language of work or name

English

0 references

publication date

20 January 2015

1 reference

Nature Reviews Clinical Oncology

2 September 2017

published in

1 reference

2 September 2017

volume

12

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

175-186

1 reference

Cancer mortality in the United Kingdom: projections to the year 2025.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

The changing pattern of kidney cancer incidence and mortality in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Tumor ablation with radio-frequency energy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Microwave ablation of hepatic malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

High-powered microwave ablation with a small-gauge, gas-cooled antenna: initial ex vivo and in vivo results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Ablation of musculoskeletal metastases: pain palliation, fracture risk reduction, and oligometastatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

The cryobiology of cryosurgical injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

The pathophysiology of thermoablation: optimizing cryoablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Irreversible electroporation: a new ablation modality--clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

High-intensity focused ultrasound: current potential and oncologic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Image-guided tumor ablation: standardization of terminology and reporting criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Utility of iodinated contrast medium in hydrodissection fluid when performing renal tumor ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Local-regional treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Society of Interventional Radiology Position Statement on Percutaneous Radiofrequency Ablation for the Treatment of Liver Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Quality improvement guidelines for radiofrequency ablation of liver tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: feasibility and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Percutaneous ablation of peribiliary tumors with irreversible electroporation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Microwave ablation for hepatic malignancies: a multiinstitutional analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: a comparison of the safety of cryoablation and radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Hepatic resection for hepatocellular carcinoma: do contemporary morbidity and mortality rates demand a transition to ablation as first-line treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

The natural history of observed enhancing renal masses: meta-analysis and review of the world literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Assessment of risk factors for complications of laparoscopic partial nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Laparoscopic versus open partial nephrectomy: analysis of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Evaluation of robotic and laparoscopic partial nephrectomy for small renal tumours (T1a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Renal tumour nephrometry score does not correlate with the risk of radiofrequency ablation complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

EAU guidelines on renal cell carcinoma: the 2010 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Minimally invasive treatment of small renal tumors: trends in renal cancer diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Percutaneous radiofrequency ablation does not affect glomerular filtration rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Percutaneous renal cryoablation: experience treating 115 tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Percutaneous renal cryoablation: local control at mean 26 months of followup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

CT-guided percutaneous cryotherapy of renal masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Prospective analysis of the safety and efficacy of percutaneous cryoablation for pT1NxMx biopsy-proven renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Percutaneous cryoablation of solitary sporadic renal cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Rising incidence of small renal masses: a need to reassess treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Image-guided ablation of Conn's adenomas in the management of primary hyperaldosteronism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Laparoscopic cryosurgery of the kidney in the porcine model: an acute histological study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Percutaneous Thermal Ablation: How to Protect the Surrounding Organs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Hepatic hemorrhage caused by percutaneous tumor ablation: radiofrequency ablation versus cryoablation in a porcine model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Focal therapy for kidney and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Partial nephrectomy for small renal masses: an emerging quality of care concern?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Renal tumor ablation is a function of patient selection and technique--not the ablation technology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.237

Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

31 March 2020

1 reference

12 December 2020

Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup

1 reference

12 December 2020

Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.

1 reference

12 December 2020

Surgical management of renal tumors 4 cm. or less in a contemporary cohort

1 reference

12 December 2020

10.1038/NRCLINONC.2014.237

Identifiers

DOI

1 reference

2 September 2017

1 reference